Serial analysis of circulating cells may predict lung cancer response to crizotinib

Among patients with non–small cell lung cancer (NSCLC) fueled by ALK gene alterations who were being treated with crizotinib , a decrease in the number of circulating tumour cells (CTCs) harbouring increased copies of the ALK gene over the first two...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pmaBcn
via IFTTT